Your Peru CRO for local and international trials
Peru has become an attractive market for foreign and domestic investment since the improvement of social-economic circumstances.
As clinical research in Peru is providing access to innovation and technology, the national entities have published several legal provisions to regulate clinical trials in Peru, under international standards and good clinical practices. Peru is known for its political stability and economic and social growth.
Peru conducts clinical trials for more than 20 years, providing training to strong local healthcare professionals in GCP and bioethics. The main therapeutic areas for clinical research in Peru are oncology, endocrinology, infectology, cardiologu and pneumology.
Peru has a population of over 31 million people, including large variety and ethnic diverse populations where deseases affecting developing countries coexist with pathologies typical of developed countries.
The country conduct trials in all phases, with a strong regulatory framework and stablished Ethic Commitees. Not only the capital, but also the smaller cities are able to conduct clinical trials.
|Population||31 488 625 hab. (2016)|
|Growth rate||0.8% (2014 est.)|
|Birth rate||18,57 births/1,000 population (2014 est.)|
|Death rate||5,99 deaths/1,000 population (2014 est.)|
|Life expectancy||73.23 years|
|Fertility rate||2,22 children born/woman (2014 est.)|
|Infant mortality rate||20,21 deaths/1,000 live births|
Cl. Justo Vigil 416, Magdalena del Mar
Tel.: (511) 714-9262